Conversely, LKB1 deficiency in human lung cancer cells with TP53 and KRAS co-mutations have inferior metabolic state for cancer cell fitness through regulation of TPI1, providing a mechanistic explanation for the rare co-mutations of LKB1/KRAS/TP53 in human lung cancer. Here, KRAS is linked to lung carcinoma.